Access cutting-edge end stage renal disease on dialysis treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Haven location
Preparing your pre-screening questions…
Access end stage renal disease on dialysis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related end stage renal disease on dialysis treatment provided free
Check if you qualify for this end stage renal disease on dialysis clinical trial in New Haven, CT
No-Cost Study Care
Local to New Haven
Convenient for CT residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The main purpose of the study is to determine if empagliflozin can reduce peritoneal glucose absorption in patients with end stage renal diease (ESRD) on peritoneal dialysis. This is a randomized, placebo controlled, acute crossover study of empagliflozin in an anticipated 30 chronic PD patients, with an 8 week "pre post" open label extension in all 30 patients where they will receive empagliflozin daily.
Sponsor: Yale University
Yes, this clinical trial (NCT05671991) has an active research site in New Haven, CT that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for end stage renal disease on dialysis treatment options in New Haven, CT, this clinical trial (NCT05671991) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end stage renal disease on dialysis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all end stage renal disease on dialysis clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in New Haven — not just this study.
Browse Ankylosing Spondylitis Trials in New Haven →